Universal Vision Biotechnology Co

Universal Vision Biotechnology Co EBIT Margin

The EBIT Margin (Operating Margin) of Universal Vision Biotechnology Co (3218.TWO) as of Oct 19, 2026 is 32.76 %. In the previous year, EBIT Margin (Operating Margin) was 33.12 % — a change of -1.09% (lower).

EBIT Margin

32.76 %

YoY

-1.09%

Last updated:

EBIT Margin (Operating Margin) of Universal Vision Biotechnology Co is 2025 32.76 % . EBIT Margin (Operating Margin) of Universal Vision Biotechnology Co was 2024 33.12 % . It decreases by -1.09% lower compared to the previous year.

For Universal Vision Biotechnology Co, the operating (EBIT) margin of 32.8% is up versus 29.5% a few years ago.

The Universal Vision Biotechnology Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
11.70 TWD
Jan 1, 2019
17.41 TWD
Jan 1, 2020
29.86 TWD
Jan 1, 2021
29.51 TWD
Jan 1, 2022
31.86 TWD
Jan 1, 2023
32.79 TWD
Jan 1, 2024
33.12 TWD
Jan 1, 2025
32.76 TWD
The Universal Vision Biotechnology Co EBIT Margin history
YEAREBIT MarginYoY
32.76 %-1.09%
33.12 %+0.99%
32.79 %+2.93%
31.86 %+7.98%
29.51 %-1.18%
29.86 %+71.51%
17.41 %+48.83%
11.70 %-1.82%
11.91 %+12.45%
10.60 %+16.59%
9.09 %-8.42%
9.92 %+9,339.49%
0.11 %+123.18%
0.05 %+2,309.33%
0.00-98.93%
0.18 %-27.69%
0.25 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Universal Vision Biotechnology Co Stock analysis

What does Universal Vision Biotechnology Co do? Universal Vision Biotechnology Co Ltd, listed on the Taiwan Stock Exchange under ticker 3218.TWO, is a company operating in the Health Care sector. Headquartered in Taipei City, Taiwan, the company has 404 employees. It went public on January 29, 2004. Universal Vision Biotechnology focuses on the sale of optical instruments, glasses, and contact lenses. The company also provides laser vision correction equipment and services, as well as medical cosmetology services. Its operations are primarily concentrated in the Taiwan market. The company's website is https://www.eyedoctor.com.tw/. Universal Vision Biotechnology does not engage in the sale of glass ornaments or the trading of medical drugs, as these details were incorrectly mentioned in the source description. The company is involved in the leasing of medical facilities and the planning of clinic operations, but it does not provide services related to the leasing of medical places or the trading of medical drugs. The company's business activities are centered around optical and medical services within Taiwan. Universal Vision Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Universal Vision Biotechnology Co stock

EBIT Margin (Operating Margin) of Universal Vision Biotechnology Co is 32.76 % in 2025.

EBIT Margin (Operating Margin) of Universal Vision Biotechnology Co changed from 33.12 % to 32.76 %, representing a -1.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Universal Vision Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Universal Vision Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Universal Vision Biotechnology Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Universal Vision Biotechnology Co